DE69913325D1 - Nephrin gen und protein - Google Patents

Nephrin gen und protein

Info

Publication number
DE69913325D1
DE69913325D1 DE69913325T DE69913325T DE69913325D1 DE 69913325 D1 DE69913325 D1 DE 69913325D1 DE 69913325 T DE69913325 T DE 69913325T DE 69913325 T DE69913325 T DE 69913325T DE 69913325 D1 DE69913325 D1 DE 69913325D1
Authority
DE
Germany
Prior art keywords
disease
protein
nephrin
gen
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69913325T
Other languages
English (en)
Other versions
DE69913325T2 (de
Inventor
Karl Tryggvason
Marjo Kestila
Ulla Lenkkeri
Minna Maennikkoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biostratum Inc
Original Assignee
Biostratum Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biostratum Inc filed Critical Biostratum Inc
Publication of DE69913325D1 publication Critical patent/DE69913325D1/de
Application granted granted Critical
Publication of DE69913325T2 publication Critical patent/DE69913325T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE1999613325 1998-03-18 1999-03-16 Nephrin Gen und Protein Expired - Fee Related DE69913325T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/040,774 US6207811B1 (en) 1998-03-18 1998-03-18 Nephrin gene and protein
US40774 1998-03-18
PCT/US1999/005578 WO1999047562A1 (en) 1998-03-18 1999-03-16 Nephrin gene and protein

Publications (2)

Publication Number Publication Date
DE69913325D1 true DE69913325D1 (de) 2004-01-15
DE69913325T2 DE69913325T2 (de) 2004-11-18

Family

ID=21912873

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1999613325 Expired - Fee Related DE69913325T2 (de) 1998-03-18 1999-03-16 Nephrin Gen und Protein

Country Status (9)

Country Link
US (3) US6207811B1 (de)
EP (1) EP1064306B1 (de)
JP (1) JP4368061B2 (de)
AT (1) ATE255595T1 (de)
AU (1) AU761601B2 (de)
CA (1) CA2323091C (de)
DE (1) DE69913325T2 (de)
ES (1) ES2213357T3 (de)
WO (1) WO1999047562A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207811B1 (en) * 1998-03-18 2001-03-27 Karl Tryggvason Nephrin gene and protein
AU4169600A (en) * 1999-03-02 2000-09-21 Biostratum, Inc. Method for the detection of congenital nephrotic syndrome
FI991369A0 (fi) * 1999-06-15 1999-06-15 Harry Holthoefer Haiman ja munuaiskeräsen ilmentäminen liukoisten proteiinimolekyylien käyttö
AT409381B (de) * 2000-03-03 2002-07-25 Gloessl Josef Dr Xylosyltransferase-gen
US6727353B2 (en) * 2000-04-14 2004-04-27 Icagen, Inc. Nucleic acid encoding Kv10.1, a voltage-gated potassium channel from human brain
WO2002037099A1 (fr) * 2000-10-27 2002-05-10 International Reagents Corporation Procede de diagnostic de la nephropathie
US20030198959A1 (en) * 2002-03-28 2003-10-23 Kurnit David M. Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
JP2003289875A (ja) * 2002-04-05 2003-10-14 Hitachi Ltd 配列提供方法及び表示システム
US20050112123A1 (en) * 2003-10-06 2005-05-26 Vaughan Michael R. Methods of treating proteinuria
JPWO2007007706A1 (ja) * 2005-07-14 2009-01-29 国立大学法人山梨大学 タンパク尿を惹起又は抑制する物質のスクリーニング方法、これに用いるプラスミド及び遺伝子導入細胞、並びにこれを用いたバイオセンサー
JP2019533139A (ja) * 2016-09-08 2019-11-14 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル ネフローゼ症候群を診断及び処置するための方法
GB2562526B (en) * 2017-05-18 2019-11-13 Cook Medical Technologies Llc Optical energy delivery and sensing apparatus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207811B1 (en) * 1998-03-18 2001-03-27 Karl Tryggvason Nephrin gene and protein

Also Published As

Publication number Publication date
US20070009952A1 (en) 2007-01-11
JP2002506883A (ja) 2002-03-05
CA2323091C (en) 2010-07-27
EP1064306B1 (de) 2003-12-03
WO1999047562A1 (en) 1999-09-23
CA2323091A1 (en) 1999-09-23
US6207811B1 (en) 2001-03-27
AU3087799A (en) 1999-10-11
US20020004589A1 (en) 2002-01-10
ATE255595T1 (de) 2003-12-15
US7105291B2 (en) 2006-09-12
ES2213357T3 (es) 2004-08-16
AU761601B2 (en) 2003-06-05
US7799529B2 (en) 2010-09-21
DE69913325T2 (de) 2004-11-18
EP1064306A1 (de) 2001-01-03
JP4368061B2 (ja) 2009-11-18

Similar Documents

Publication Publication Date Title
DK1266025T3 (da) Protein-scaffolds for antistof-mimetika og andre bindingsproteiner
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
DE69913325D1 (de) Nephrin gen und protein
DK1187591T3 (da) IBD-associerede mikrobielle antigener og fremgangsmåder til at anvende samme
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
CY1111006T1 (el) Εκριμματαση ασθενειας alzheimer
WO2005019470A3 (en) Detecting and profiling molecular complexes
DE60030145D1 (de) Nachweisverfahren für kurze sequenzvarianten
DE60138715D1 (de) Tnf-rezeptor-ähnliche moleküle und deren anwendungen
WO2002014485A3 (en) Kallikrein gene
DE50109723D1 (de) Nachweis und identifikation von bakteriengruppen
ATE383172T1 (de) Oligonukleotide welche spezifisch retrovirale nukleokapsid-proteine binden
DK1082423T3 (da) Cyclin E2-gener og -proteiner
ATE389881T1 (de) Detektion von kleinen molekülen mit piezo- elektrischem sensor
WO2003002724A3 (en) Proteins, druggable regions of proteins and target analysis for chemistry of therapeutics
ATE384263T1 (de) Verfahren zur bestimmung von biologischen agenzien in lebenden zielzellen
BR9710919A (pt) Proteina purificada sr-p70
DK1075523T3 (da) Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf
DE60139113D1 (de) 18477, eine menschliche proteinkinase und deren verwendung
ATE313631T1 (de) Dna polymerase lambda und ihre verwendungen
WO1999005159A3 (de) Staphylococcus-spezifisches nucleinsäuremolekül, kit und verwendung nucleinsäuremolekül, nucleinsauremolekul, kit und verwendung
DE59907570D1 (de) Nachweis von zellen mittels spezifischer zellwand-bindender domänen (cbd) von zellwand-bindenden proteinen
DK1002056T3 (da) ppGpp-syntease og ekspressionssystem til forbedret fremstilling af protein af interesse
ATE528392T1 (de) Neues protein und dessen dns
DE50113417D1 (de) Zellbindende nukleinsäuremoleküle (aptamere)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee